RESUMEN
This study aimed to develop a computed tomography (CT)-based radiomics model to predict the outcome of COVID-19 pneumonia. In total of 44 patients with confirmed diagnosis of COVID-19 were retrospectively enrolled in this study. The radiomics model and subtracted radiomics model were developed to assess the prognosis of COVID-19 and compare differences between the aggravate and relief groups. Each radiomic signature consisted of 10 selected features and showed good performance in differentiating between the aggravate and relief groups. The sensitivity, specificity, and accuracy of the first model were 98.1%, 97.3%, and 97.6%, respectively (AUC = 0.99). The sensitivity, specificity, and accuracy of the second model were 100%, 97.3%, and 98.4%, respectively (AUC = 1.00). There was no significant difference between the models. The radiomics models revealed good performance for predicting the outcome of COVID-19 in the early stage. The CT-based radiomic signature can provide valuable information to identify potential severe COVID-19 patients and aid clinical decisions.